期刊文献+

利用GST融合多肽制备人源膜受体多抗的研究

The Research of Preparing Polyclonal Antibody Against Human Membrane Receptor Immunized by Its GST Fusion Polypeptide
下载PDF
导出
摘要 膜受体是一类膜蛋白,而全长的膜蛋白很难通过基因工程获得,这给制备该类蛋白的抗体增加了难度。为了探索一条制备膜受体多克隆抗体的新途径,通过基因重组技术,将膜受体的抗原决定簇与GST标签进行融合表达,然后免疫新西兰兔,获得了相应的多克隆抗体。结果表明,利用融合GST的多肽进行抗体制备的方法是可行的。 Membrane receptors belong to a kind of membrane proteins,the full length protein of which is hard to be expressed in vitro.Therefore,it can be more difficult to obtain antibody against this kind of proteins. In order to pave a new way for preparing polyclonal antibody against membrane receptors,the antigenic determinant of membrane receptors is expressed in fusion with GST by using genetic recombination technique.The pure GST fusion polypeptide is then used to immunize a New Zealand rabbit.As a result,the polyclonal antibody is obtained.The results of ELISA and Western blot indicated that it is feasible to prepare antibody with GST fusion polypeptide.
出处 《浙江理工大学学报(自然科学版)》 2010年第4期636-640,共5页 Journal of Zhejiang Sci-Tech University(Natural Sciences)
基金 国家863项目(2007AA021703) 浙江省教育厅项目(Y200806021) 浙江省"新苗人才计划"项目(2008R40G2060038)
关键词 GST融合多肽 膜受体 抗原决定簇 抗体 GST fusion polypeptide membrane receptor antigenic determinant antibody
  • 相关文献

参考文献2

二级参考文献64

  • 1[1]Zheng Y H,Sentsui H,Kono Y,et al.Mutations occurring during serial passage of Japanese equine infectious anemia vi rus in primary horse macrophages[J].Virus Res,2000,68(1):93-98.
  • 2[2]Pikora C A.Glycosylation of the ENV spike of primate immunodeficiency viruses and antibody neutralization[J].Curr HIV Res,2004,2(3):243-254.
  • 3[3]Cook R F,Berger S L,Rushlow K E,et al.Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein[J].J Virol,1995,69(3):1493-1499.
  • 4[4]Shen T,Liang H,Tong X,et al.Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resuited in reversion of virulence[J].Vaccine,2006,24(6):738-749.
  • 5[5]Liang H,He X,Shen R X,et al.Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV[J].Arch Virol,2006,151(7):1387-1403.
  • 6[6]Garrity R R,Rimmelzwaan G,Mnassian A,et al.Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope[J].J Immunol,1997,159(1):279-289.
  • 7[7]Zhou W,Cook R F,Cook S J,et al.Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV)[J].Vet Microhiol,2002,88(2):127-151.
  • 8[8]Andre S,Seed B,Eberle J,et al.Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage[J].J Virol,1998,72(2):1497-1503.
  • 9[9]Vinner L,Nielsen H V,Bryder K,et al.Gene gun DNA vaccination with Revindependent synthetic HIV-1 gp160 envelope gene using mammalian codons[J].Vaccine,1999,17(17):2166-2175.
  • 10[10]Ho S N,Hunt H D,Horton R M,et al.Site-directed mutagenesis by overlap extension using the polymerase chain reaction[J].Gene,1989,77(1):51-59.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部